Main Menu
About
Overview
Amgen History
Mission and Values
Leadership
Awards and Accolades
How We Operate
Overview
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Research and Development Strategy
Undruggable Podcast
DNA Unlocked
Pipeline
Scientific Advisory Boards
Amgen Science
Amgen Competitive Grants
Biosimilars
Clinical Trials
Overview
About Clinical Trails
Amgen Clinical Trails
Clinical Trial Diversity and Representation
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support program
Investigator Sponsored Studies
Scientific Community Initiatives
Overview
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
Overview
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Counterfeit Drug Statement
Safety Data Sheets
Global Patient Safety
Overview
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
Environmental, Social & Governance Report 2020
Corporate Responsibility
Strategy & Governance
Overview
Amgen’s Commitment to Patients
Our Approach to Pricing,
Access and Affordability
Access Approaches, Treatments, and Collaborations
Transformative Treatments, Approaches, and Technology
Shaping the Future of Healthcare
Access to Medicine
U.S. Reimbursement Support Services and Financial Assistance Programs
Access to Medicines Initiatives Outside the U.S.
Access to Investigational Medicines
Amgen Foundation
Overview
Amgen Inspires
Amgen Foundation Grants
About the Amgen Foundation
Commitment to Community
Overview
Staff Engagement Programs
Independent Medical Education Funding
U.S. Healthcare Donations
Non-Healthcare Donations and Sponsorships
Equipment Donations
Donation and Grant Recipients
Diversity, Inclusion and Belonging
Amgen's Commitment to Diversity, Inclusion and Belonging
Environment
Overview
Performance
2027 Plan
Sustainable by Design
Case Studies
Responsible Sourcing
Supplier Diversity
Supplier Sustainability
Workplace
Safety
Wellness
Reporting and Metrics
Overview
Archived Reports
Summary of Data
CDP
Stakeholder Engagement
Stories
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
Newsroom
Partners
Investors
Careers
Amgen Worldwide
Overview
Research and Development Strategy
Undruggable Podcast
DNA Unlocked
Overview <i class="fa fa-external-link"></i>
Scientific Advisory Boards
Pipeline <i class="fa fa-external-link"></i>
Amgen Competitive Grants <i class="fa fa-external-link"></i>
Clinical Trials
Scientific Community Initiatives
Manufacturing
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
About
Overview
Amgen History
Mission and Values
Leadership
Awards and Accolades
How We Operate
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Research and Development Strategy
Undruggable Podcast
DNA Unlocked Podcast
Pipeline
Scientific Advisory Boards
Amgen Science
Amgen Competitive Grants
Biosimilars
Clinical Trials
About Clinical Trials
Amgen Clinical Trials
Clinical Trial Diversity and Representation
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support Program
Investigator Sponsored Studies
Scientific Community Initiatives
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Counterfeit Drug Statement
Safety Data Sheets
Global Patient Safety
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
Environmental, Social & Governance Report 2020
Corporate Responsibility Strategy & Governance
Amgen's Commitment to Patients
Our Approach to Pricing, Access and Affordability
Access Approaches, Treatments, and Collaborations
Transformative Treatments, Approaches and Technology
Shaping the Future of Healthcare
Access to Medicine
U.S. Reimbursement Support Services and Financial Assistance Programs
Access to Medicines Initiatives Outside the U.S.
Access to Investigational Medicines
Amgen Foundation
Amgen Inspires
About the Amgen Foundation
Amgen Foundation Grants
Commitment to Community
Staff Engagement Programs
Independent Medical Education Funding
U.S. Healthcare Donations
Non-Healthcare Donations and Sponsorships
Equipment Donations
Donation and Grant Recipients List
Diversity, Inclusion & Belonging
Amgen's Commitment to Diversity, Inclusion and Belonging
Environment
Performance
2027 Plan
Sustainable by Design
Case Studies
Responsible Sourcing
Supplier Diversity
Supplier Sustainability
Workplace
Safety
Wellness
Reporting and Metrics
Summary of Data
CDP
Stakeholder Engagement
Archived Reports
Stories
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
Newsroom
Partners
Investors
Careers
X
Home
>
Stories
>
Science and Innovation
>
Science and Innovation Stories
SCIENCE & INNOVATION
12.17.2021
Teneobio Acquisition Adds Talent and New Types of Antibodies to Amgen
Read more
All Stories <i class="fa fa-angle-down"></i><i class="fa fa-angle-up"></i>
All
PATIENTS
RESPONSIBILITY
LEADERSHIP
SCIENCE & INNOVATION
PEOPLE & CULTURE
All
PATIENTS
RESPONSIBILITY
LEADERSHIP
SCIENCE & INNOVATION
PEOPLE & CULTURE
SCIENCE & INNOVATION
01.14.2022
Teneobio Acquisition Adds Talent and New Types of Antibodies to Amgen
SCIENCE & INNOVATION
12.17.2021
Behind the Discovery of a New Homegrown Molecule for Severe Asthma
SCIENCE & INNOVATION
12.17.2021
Severe Asthma and TSLP: Fast Facts
SCIENCE & INNOVATION
12.16.2021
Accelerating R&D to Speed Medicines to Patients
SCIENCE & INNOVATION
12.10.2021
Advancing All Angles of Care for Cancer Patients
SCIENCE & INNOVATION
12.09.2021
Innovation² with Jane Parnes and Nina Tandon
SCIENCE & INNOVATION
11.23.2021
In a First for Industry, Murielle Veniant-Ellison Honored With 2022 Havel Lectureship
SCIENCE & INNOVATION
11.17.2021
A New Way to Connect Psoriatic Disease Patients with Healthcare Providers
SCIENCE & INNOVATION
11.11.2021
COVID-19 Accelerates Biopharmaceutical Innovation, Bradway Says at Annual Investor Conference
SCIENCE & INNOVATION
11.05.2021
Amgen Featured in Video Series Highlighting Leading Innovators
SCIENCE & INNOVATION
10.26.2021
Building Healthcare System Resilience With Biosimilars
SCIENCE & INNOVATION
10.21.2021
Introducing Undruggable, a New Serial Podcast from Amgen R&D Exploring how Multispecifics can Usher in the Next Wave of Drug Discovery
Load more
Loading...
